According to the MHRA’s chief quality and access officer, Dr Laura Squire, there is a need for “risk proportionate regulation of AIaMD […] which takes into account the risks of these ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has put out a call for developers of artificial intelligence as a medical device (AIaMD) technology to join its new regulatory ...